Target intelligence / Profile preview

Lipid bilayer of cell membranes (None)

Target
None
Molecular classification
Other (structural feature), not a receptor, enzyme, ion channel, or transporter
01

Overview

The lipid bilayer of cell membranes consists of two sheets of amphipathic lipid molecules, primarily phospholipids, with hydrophilic heads facing the aqueous environment and hydrophobic tails sequestered inward[1][3][5][7][9]. This structure forms a dynamic, self-sealing barrier that is largely impermeable to water-soluble molecules and ions, necessitating specialized protein channels and transporters for regulated passage[1][3][7][9]. Membrane proteins are embedded in or associated with the bilayer, enabling signaling, transport, and enzymatic activities[2][5][7][8]. The bilayer is fluid due to lateral movement of lipids and proteins, which is essential for membrane function; fluidity is modulated by fatty acid properties and the presence of cholesterol[5][7]. The lipid bilayer is crucial for maintaining cellular homeostasis and compartmentalization but is not typically a direct drug target; it is, however, affected by toxins, certain drugs, and disease processes[8][9].

Other names
Lipid bilayerphospholipid bilayercell membrane bilayerbiological membrane bilayer
02

Mechanism of action

Disruption of membrane integrity or permeability (e.g., pore formation by toxins); Alteration of membrane fluidity or lipid composition, modifying function of embedded proteins; Use of artificial lipid bilayers for drug delivery (liposomes)

03

Biological functions

Structural barrier between cell and environmentSelective permeability for ions and moleculesScaffold for membrane proteinsMaintains membrane fluidity and self-healingParticipates in signaling by hosting receptors and lipids with signaling roles
04

Disease associations

Involvement in infection (site of entry for some viruses and toxins)Altered membrane properties in neurodegenerative disease (such as amyloid interactions)Indirect roles in cancer, cardiovascular disease, and inflammation through interactions with embedded drugs and proteins
05

Safety considerations

Membrane disruption can result in cell death or toxicityOff-target effects via non-specific interaction with host cell membranesChallenges in targeting membrane for therapy due to its ubiquity and essential function
06

Interacting drugs

Amphipathic or membrane-disrupting drugs (such as some antibiotics, e.g., polymyxins)

2 more in the full profile.

07

Biomarkers

None directly; membrane composition and fluidity may be assessed indirectly for certain diseases

Beyond the preview

Go deeper on Lipid bilayer of cell membranes (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid bilayer of cell membranes (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call